• Sadybekov AV, Duro MV, Wang S, Ebright B, Dikeman D, Hugo C, Kerman BE, Ma QL, Nazarova AL, Sadybekov AA, Asante I, Louie SG, Katritch V, Yassine HN. Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer’s disease and other neurodegenerative disorders. NPJ Drug Discov. 2026;3(1):2. doi: 10.1038/s44386-025-00035-0. Epub 2026 Jan 7. PMID: 41523267; PMCID: PMC12779542.
  • Varga BR, Bernhard SM, El Daibani A, Zaidi SA, Lam JH, Aguilar J, Appourchaux K, Nazarova AL, Kouvelis A, Shinouchi R, Hammond HR, Eans SO, Weinreb V, Margolis EB, Fay JF, Huang XP, Pradhan A, Katritch V, McLaughlin JP, Majumdar S, Che T. Structure-guided design of partial agonists at an opioid receptor. Nat Commun. 2025 Mar 13;16(1):2518. doi: 10.1038/s41467-025-57734-5. PMID: 40082451; PMCID: PMC11906898.
  • Sadybekov AV, Katritch V. Computational approaches streamlining drug discovery. Nature. 2023 Apr;616(7958):673-685. doi: 10.1038/s41586-023-05905-z. Epub 2023 Apr 26. PMID: 37100941.
  • Faouzi A, Wang H, Zaidi SA, DiBerto JF, Che T, Qu Q, Robertson MJ, Madasu MK, El Daibani A, Varga BR, Zhang T, Ruiz C, Liu S, Xu J, Appourchaux K, Slocum ST, Eans SO, Cameron MD, Al-Hasani R, Pan YX, Roth BL, McLaughlin JP, Skiniotis G, Katritch V, Kobilka BK, Majumdar S. Structure-based design of bitopic ligands for the µ-opioid receptor. Nature. 2023 Jan;613(7945):767-774. doi: 10.1038/s41586-022-05588-y. Epub 2022 Nov 30. PMID: 36450356; PMCID: PMC10328120.
  • Sadybekov AA, Sadybekov AV, Liu Y, Iliopoulos-Tsoutsouvas C, Huang XP, Pickett J, Houser B, Patel N, Tran NK, Tong F, Zvonok N, Jain MK, Savych O, Radchenko DS, Nikas SP, Petasis NA, Moroz YS, Roth BL, Makriyannis A, Katritch V. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds. Nature. 2022 Jan;601(7893):452-459. doi: 10.1038/s41586-021-04220-9. Epub 2021 Dec 15. PMID: 34912117; PMCID: PMC9763054.
  • Patel N, Huang XP, Grandner JM, Johansson LC, Stauch B, McCorvy JD, Liu Y, Roth B, Katritch V. Structure-based discovery of potent and selective melatonin receptor agonists. Elife. 2020 Mar 2;9:e53779. doi: 10.7554/eLife.53779. PMID: 32118583; PMCID: PMC7080406.